DYNAVAX TECHNOLOGIES news, videos and press releases - Page 2
For more news please use our advanced search feature.
DYNAVAX TECHNOLOGIES - More news...
DYNAVAX TECHNOLOGIES - More news...
- Dynavax to Present at the H.C. Wainwright 4th Annual Hepatitis B Virus Virtual Conference
- Dynavax to Present at the H.C. Wainwright 25th Annual Global Investment Conference
- Dynavax Reports Second Quarter 2023 Financial Results and Raises Full Year Revenue Guidance
- Dynavax to Report Second Quarter 2023 Financial Results and Host Conference Call on August 3, 2023
- Dynavax to Present at Upcoming Investor Conferences
- Dynavax to Present at the JMP Securities Life Sciences Conference
- Dynavax Reports First Quarter 2023 Financial Results
- Dynavax to Report First Quarter 2023 Financial Results and Host Conference Call on May 2, 2023
- Dynavax to Present at the Cowen 43rd Annual Health Care Conference
- Dynavax Announces Great Britain Marketing Authorization for HEPLISAV B®, a Two-Dose Adult Hepatitis B Adjuvanted Vaccine
- Dynavax Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Full Year 2023 Financial Guidance
- Dynavax to Report Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on February 23, 2023
- Dynavax Announces Uplisting to the Nasdaq Global Select Market
- Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Financial Highlights and Phase 1 Shingles Topline Results
- Dynavax to Present at Two Upcoming Investor Conferences
- Dynavax Reports Third Quarter 2022 Financial Results
- Dynavax to Report Third Quarter Financial Results and Host Conference Call on November 3, 2022
- Dynavax Announces First Participant Dosed in a Phase 2 Clinical Trial Evaluating an Adjuvanted Plague Vaccine
- Dynavax to Present at the H.C. Wainwright 24th Annual Global Investment Conference
- Thinking about buying stock in AN2 Therapeutics, AMTD IDEA Group, Dynavax Technologies, Yelp, or Honest Company?
- Dynavax Reports Second Quarter 2022 Financial Results
- Dynavax to Report Second Quarter Financial Results and Host Conference Call on August 4, 2022
- Dynavax to Present at the H.C. Wainwright Global Investment Conference
- Dynavax Reports First Quarter 2022 Financial Results
- Dynavax to Report First Quarter 2022 Financial Results and Host Conference Call on May 5, 2022
- Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Dynavax Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Full Year 2022 Financial Guidance
- Dynavax to Report Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call on February 28, 2022
